United States set
language
Menu Shopping cart $0 Search

References to Prostate Cancer Panel

  • Abrahamsson PA, Andersson C, Bjork T, Fernlund P, Lilja H, Murne A, Weiber H. Radioimmunoassay of beta-microseminoprotein, a prostatic-secreted protein present in sera of both men and women. Clin Chem. 1989 Jul;35 (7):1497-503
  • Bjartell AS, Al-Ahmadie H, Serio AM, Eastham JA, Eggener SE, Fine SW, Udby L, Gerald WL, Vickers AJ, Lilja H, Reuter VE, Scardino PT. Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy. Clin Cancer Res. 2007 Jul 15;13 (14):4130-8
  • Chen X, Halberg RB, Ehrhardt WM, Torrealba J, Dove WF. Clusterin as a biomarker in murine and human intestinal neoplasia. Proc Natl Acad Sci U S A. 2003 Aug 5;100 (16):9530-5
  • Choi-Miura NH, Oda T. Relationship between multifunctional protein "clusterin" and Alzheimer disease. Neurobiol Aging. 1996 Sep-Oct;17 (5):717-22
  • Ghiggeri GM, Bruschi M, Candiano G, Rastaldi MP, Scolari F, Passerini P, Musante L, Pertica N, Caridi G, Ferrario F, Perfumo F, Ponticelli C. Depletion of clusterin in renal diseases causing nephrotic syndrome. Kidney Int. 2002 Dec;62 (6):2184-94
  • Girton RA, Sundin DP, Rosenberg ME. Clusterin protects renal tubular epithelial cells from gentamicin-mediated cytotoxicity. Am J Physiol Renal Physiol. 2002 Apr;282 (4):F703-9
  • Hidaka S, Kranzlin B, Gretz N, Witzgall R. Urinary clusterin levels in the rat correlate with the severity of tubular damage and may help to differentiate between glomerular and tubular injuries. Cell Tissue Res. 2002 Dec;310 (3):289-96
  • Ishii A, Sakai Y, Nakamura A. Molecular pathological evaluation of clusterin in a rat model of unilateral ureteral obstruction as a possible biomarker of nephrotoxicity. Toxicol Pathol. 2007 Apr;35 (3):376-82
  • Jones SE, Jomary C. Clusterin. Int J Biochem Cell Biol. 2002 May;34 (5):427-31
  • Kim BM, Kim SY, Lee S, Shin YJ, Min BH, Bendayan M, Park IS. Clusterin induces differentiation of pancreatic duct cells into insulin-secreting cells. Diabetologia. 2006 Feb;49 (2):311-20
  • Krijnen PA, Cillessen SA, Manoe R, Muller A, Visser CA, Meijer CJ, Musters RJ, Hack CE, Aarden LA, Niessen HW. Clusterin: a protective mediator for ischemic cardiomyocytes?. Am J Physiol Heart Circ Physio. 2005 Nov;289 (5):H2193-202
  • Kruger S, Mahnken A, Kausch I, Feller AC. Value of clusterin immunoreactivity as a predictive factor in muscle-invasive urothelial bladder carcinoma. Urology. 2006 Jan;67 (1):105-9
  • Morrissey C, Lakins J, Moquin A, Hussain M, Tenniswood M. An antigen capture assay for the measurement of serum clusterin concentrations. J Biochem Biophys Methods. 2001 Mar 28;48 (1):13-21
  • Nam RK, Reeves JR, Toi A, Dulude H, Trachtenberg J, Emami M, Daigneault L, Panchal C, Sugar L, Jewett MA, Narod SA. A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis. J Urol. 2006 Apr;175 (4):1291-7
  • Newkirk MM, Apostolakos P, Neville C, Fortin PR. Systemic lupus erythematosus, a disease associated with low levels of clusterin/apoJ, an antiinflammatory protein. J Rheumatol. 1999 Mar;26 (3):597-603
  • Patel NV, Wei M, Wong A, Finch CE, Morgan TE. Progressive changes in regulation of apolipoproteins E and J in glial cultures during postnatal development and aging. Neurosci Lett. 2004 Nov 23;371 (2-3):199-204
  • Reeves JR, Dulude H, Panchal C, Daigneault L, Ramnani DM. Prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy. Clin Cancer Res. 2006 Oct 15;12 (20 Pt 1):6018-22
  • Rodriguez-Pineiro AM, de la Cadena MP, Lopez-Saco A, Rodriguez-Berrocal FJ. Differential expression of serum clusterin isoforms in colorectal cancer. Mol Cell Proteomics. 2006 Sep;5 (9):1647-57
  • Schroder FH. Prostate specific antigen and other markers for prostate cancer. J Urol. 2006 Apr;175 (4):1199-200
  • Stoop MP, Dekker LJ, Titulaer MK, Burgers PC, Sillevis Smitt PA, Luider TM, Hintzen R